|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Evaluation of gaps in Cervical Cancer Screening and Prevention among women living with HIV (WLHIV) in a tertiary teaching hospital in Malaysia. 2021 – 2023
|
DOM UM-RSFG Grant
|
|
2
|
Facilitators and Barriers to Integrating Mental Health Services into routine outpatient HIV Clinical Care for women living with HIV (WLWH) at the University Malaya Medical Centre, Malaysia
|
amfAR, The Foundation for AIDS Research, with support from the US National Institutes of Health’s Fogarty International Center and the National Institute of Mental Health (CHIMERA; D43TW011302)
|
|
3
|
Assessment of Tuberculosis Prophylaxis Therapy in HIV patients in University Malaya Medical Centre: A Retrospective Cross-sectional Study, 2019 - 2021
|
No funding
|
|
4
|
Neurocognitive disorders among people living with HIV in Malaysia, 2019 – 2021
|
Fogarty International Center and the National Institute of Stroke and Neurological Disorders, National Institutes of Health
|
|
5
|
Substance use, Stigma, Depression and Disability among Adults with HIV in Asia (S2D2) Pilot Study, 2019-2020
|
Therapeutics Research, Education and AIDS Training in Asia (TREAT Asia), The Foundation for AIDS Research, amfAR, with funding from the US National Institutes of Health
|
|
6
|
Facilitators and barriers to the integration of screening for HIV-associated Neurocognitive Disorders (HAND) in routine clinical care among people living with HIV (PLHV) at a tertiary care centre in Malaysia
|
amFAR, The Foundation of AIDS Research with the support from the US National Institutes of Health
|
|
7
|
Pre-implementation study to the integration of screening for HIV-associated Neurocognitive Disorders (HAND) in routine clinical care among people living with HIV at a tertiary care centre in Malaysia
|
UM Partnership Grant
|
|
8
|
Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV prevention among female sex workers in Malaysia
|
Yale University
|
|
9
|
Retrospective review of Kaposi Sarcoma among HIV patients
|
No funding
|
|
10
|
D2EFT: Dolutegravir and Darunavir Evaluation in Adults Failing Therapy A Phase IIIB/IV randomised open-label trial to compare dolutegravir with pharmaco-enhanced darunavir versus dolutegravir with predetermined nucleosides versus recommended standard of care antiretroviral regimens in patients with HIV-1 infection who have failed recommended first line therapy.
|
Kirby Institute
|
|
11
|
GILEAD: GS-US-380-4458 A phase 3, randomised, double blind study to evaluate the safety and efficacy of fixed dose combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in treatment Naive, HIV-1 and hepatitis B co-infected adults.
|
Gilead Sc. Inc.
|
|
12
|
Developing an artificial intelligence-based M-health intervention to increase HIV testing in Malaysia
|
US NIH in collaboration with Yale University
|
|
13
|
Developing An Artificial Intelligence Chatbot To Promote Hiv Testing
|
NIH in collaboration with Yale University
|
|
14
|
Development And Testing Of A Mobile Application To Enhance Hiv Prevention Cascade In Malaysia MSM
|
NIH in collaboration with University of Connecticut
|
|
15
|
Scaling Up HIV PrEP in primary care and community based organizations
|
Global Fund
|
|
16
|
IeDEA Asia-Pacific Research Collaboration: TREAT Asia HIV Observational Database (TAHOD)
|
US NIH
|
|
17
|
Facilitators and barriers to the integration of depression and substance use screening and linkage to care in an infectious disease clinic of a tertiary-care hospital in Malaysia
|
amFAR, The Foundation of AIDS Research with the support from the US National Institutes of Health
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Young People’s Opinions on Drug Policy, and Drug Use Trends and HIV risk behaviours in Malaysia (YOUTH) – ‘Project Youth’
|
UNODC
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Knowledge, Attitude and Perception of Infection Control Among Health Care Workers in University Malaya Medical Centre (UMMC), 2019 – 2022
|
No funding
|
|
2
|
Evaluation and Recommendation for Infection Control in Malaysia (MY-ERIC): Integration of multifaceted approaches to reduce multidrug-resistant organisms infections in Malaysia. Subproject 4(SP4): Infection control and antibiotic stewardship program to improve patient’s outcome, 2022 - 2024
|
Trans-disciplinary Research Grant Scheme (TRGS Grant)
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
A Clinically-Oriented Antimicrobial Resistance Surveillance Network for Healthcare-associated infections ACORN-HAI study
|
Wellcome Trust
|
|
2
|
Identifying targets for quality improvement in antimicrobial prescribing in a Malaysian critical care areas in a tertiary care university teaching hospital: a repeated point prevalence survey, 2022 to 2023
|
Trans-disciplinary Research Grant Scheme (TRGS Grant)
|
|
3
|
Diagnostic Approaches in Severe Pneumonia (D-PRISM) study
|
European Society of Clinical Microbiology and Infectious Diseases (ESCMI)
|
|
4
|
Epidemiology and determinants of outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care EUROBACT-2
|
European Society of Clinical Microbiology and Infectious Diseases (ESCMI)
|
|
5
|
Knowledge, attitude, perception and prescribing patterns of pneumonia in the emergency department
|
No funding
|
|
6
|
Improving appropriate use of Meropenem in University Malaya Medical Centre (UMMC), Malaysia
|
Pfizer
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Staphylococcus aureus bacteremia among COVID patients
|
No funding
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Investigator Driven Randomized Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection GAME CHANGER study
|
Shionogi
|
|
2
|
Early oral step-down antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteremia INVEST study
|
Singapore’s National Research Foundation Central Gap Fun
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Assessment of post-acute COVID syndrome and serological response in confirmed COVID-19 patients in the University of Malaya Medical Centre
|
UMSC CARE Grant
|
|
2
|
A Randomised, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Safety and Efficacy of Aerosolised Novaferon + SOC vs. Placebo + SOC in Hospitalised Adult Patients with Moderate to Severe COVID-19, 2021 – 2022
|
Industry sponsored Genova Inc
|
|
3
|
SOLIDARITY TRIAL PLUS, 2021 – 2022
|
World Health Organization
|
|
4
|
Assessing immune responses to COVID-19 vaccination among people living with HIV (PLWH), 2021 - 2023,
|
No funding
|
|
5
|
Clinical Characteristics of COVID-19 affected individuals in UMMC: a retrospective analysis, 2020 – 2022
|
No funding
|
|
6
|
Stigma, resilience, and COVID-19 in healthcare workers working at a tertiary care centre in Malaysia. 2020 – 2021
|
No funding
|
|
7
|
Evaluation of home monitoring system for patients with COVID-19 (CoSMoS) in University Malaya Medical Centre, 2021
|
No funding
|
|
8
|
An Open-label, Randomised, Adaptive Cross-over Interventional Study to Evaluate the Efficacy of Tocilizumab versus Corticosteroids in hospitalised COVID-19 patients with high risk of progression, 2020.
|
Tocilizumab
|
|
9
|
Learning and delivering healthcare through lenses; the usage of smart glasses and telemedicine in caring for patients with infectious disease and medical education in the era of a pandemic, 2020
|
No funding
|
|
10
|
World Heart Federation (WHF) COVID-19 and Cardiovascular Disease Study
|
World Heart Federation
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients Bling III study
|
Australian National Health and Medical Research Council
|
|
2
|
Population Pharmacokinetics and Pharmacodynamics of Colistin and Polymyxin B in Non-Critically Ill and Critically Ill Patients with Multidrug-resistant Gram-negative Bacterial Infections collaborate study
|
International Society of Antimicrobial Chemotherapy
|
|
3
|
Pneumonia dosing in critically ill patients pneudos study
|
Australian National Health and Medical Research Council
|
|
No.
|
Title of the studies/trials
|
Funding source
|
|
1
|
Epidemiology and Etiology of Wound Infections in Southeast Asia - Malaysia, 2020 – 2023
|
Naval Medical Research Unit Two (NAMRU-2)
|
|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
|
|
7
|
|
|
8
|
|
|
9
|
|
| 10 |
|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
Last Update: 23/10/2024